762680

506414

FERMENTA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Fermenta Biotech Ltd Share Price Today

FERMENTA BIOTECH LTD. made its stock market debut on 20 April 2026 and is currently trading at ₹342.6, up by ₹5.39 from the previous close. The stock touched an intraday high of ₹348.00 and a low of ₹334.05 during the latest trading session.

Fermenta Biotech Ltd performance

Today’s low Today’s high
₹ 334.05 ₹ 348.00
₹ 345.00
52 week low 52 week high
₹ 248.85 ₹ 356.85
₹ 345.00
Open Price ₹ 338.00
Prev. Close ₹ 337.20
Volume (Shares) 71582.00
Total traded value ₹ 246.95
Upper Circuit ₹ 404.60
Lower Circuit ₹ 269.80
info

Investment Returns

Over 1 Month 14.63% Over 3 Months 5.90% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Fermenta Biotech Ltd fundamentals


  • Market cap (Cr) 1,015.40
  • P/E Ratio (TTM) 15.49
  • Beta -0.01
  • Book Value / share 143.79
  • Return on equity 19.48%
  • EPS (TTM) 20.14
  • Dividend yield 1.08%
  • Net profit/quarter (Cr) 21.57
info icon alternate text
  • Market cap (Cr) 1,000.20
  • P/E Ratio (TTM) 15.49
  • Beta 0.69
  • Book Value / share 143.79
  • Return on equity 19.48%
  • EPS (TTM) 20.14
  • Dividend yield 1.08%
  • Net profit/quarter (Cr) 21.57
info icon alternate text

Fermenta Biotech Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 109.88
Operating Expense 95.89
Net Profit 21.57
Net Profit Margin (%) 19.63
Earnings Per Share (EPS) 5.26
EBITDA 37.01
Effective Tax Rate (%) 26.02
Particulars DEC 2025 (Values in Cr)
Revenue 114.24
Operating Expense 98.98
Net Profit 11.76
Net Profit Margin (%) 10.29
Earnings Per Share (EPS) 4.56
EBITDA 24.79
Effective Tax Rate (%) 29.11
Particulars SEP 2025 (Values in Cr)
Revenue 107.12
Operating Expense 91.87
Net Profit 14.72
Net Profit Margin (%) 13.74
Earnings Per Share (EPS) 5.05
EBITDA 28.49
Effective Tax Rate (%) 29.12
Particulars JUN 2025 (Values in Cr)
Revenue 119.02
Operating Expense 105.15
Net Profit 16.23
Net Profit Margin (%) 13.63
Earnings Per Share (EPS) 5.57
EBITDA 31.38
Effective Tax Rate (%) 28.56
Particulars MAR 2025 (Values in Cr)
Revenue 122.04
Operating Expense 97.94
Net Profit 29.31
Net Profit Margin (%) 24.01
Earnings Per Share (EPS) 10.05
EBITDA 36.56
Effective Tax Rate (%) -4.79
Particulars MAR 2026 (Values in Cr)
Revenue 450.25
Operating Expense 391.87
Net Profit 64.28
Net Profit Margin (%) 14.27
Earnings Per Share (EPS) 20.43
EBITDA 121.66
Effective Tax Rate (%) 27.96
Particulars MAR 2025 (Values in Cr)
Revenue 430.53
Operating Expense 367.78
Net Profit 67.62
Net Profit Margin (%) 15.70
Earnings Per Share (EPS) 23.18
EBITDA 111.79
Effective Tax Rate (%) 9.15
Particulars MAR 2024 (Values in Cr)
Revenue 307.09
Operating Expense 310.85
Net Profit -18.74
Net Profit Margin (%) -6.10
Earnings Per Share (EPS) -3.37
EBITDA 36.14
Effective Tax Rate (%) -306.72
Particulars MAR 2023 (Values in Cr)
Revenue 328.91
Operating Expense 335.76
Net Profit -57.00
Net Profit Margin (%) -17.32
Earnings Per Share (EPS) -19.75
EBITDA -12.68
Effective Tax Rate (%) 1.67
Particulars MAR 2022 (Values in Cr)
Revenue 387.96
Operating Expense 352.93
Net Profit 30.24
Net Profit Margin (%) 7.79
Earnings Per Share (EPS) 10.48
EBITDA 83.46
Effective Tax Rate (%) 28.97
Particulars MAR 2025 (Values in Cr)
Book Value / Share 124.33
ROE % 23.45
ROCE % 20.20
Total Debt to Total Equity 0.39
EBITDA Margin 26.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 100.04
ROE % -5.82
ROCE % 2.96
Total Debt to Total Equity 0.59
EBITDA Margin 11.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 109.27
ROE % -7.57
ROCE % -0.19
Total Debt to Total Equity 0.67
EBITDA Margin 7.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 129.00
ROE % 4.11
ROCE % 7.36
Total Debt to Total Equity 0.64
EBITDA Margin 17.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 125.00
ROE % 12.70
ROCE % 12.43
Total Debt to Total Equity 0.68
EBITDA Margin 24.10
Particulars MAR 2025 (Values in Cr)
Book Value / Share 130.26
ROE % 19.48
ROCE % 17.61
Total Debt to Total Equity 0.37
EBITDA Margin 26.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 108.83
ROE % -2.38
ROCE % 4.10
Total Debt to Total Equity 0.55
EBITDA Margin 14.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 116.45
ROE % 0.84
ROCE % 3.77
Total Debt to Total Equity 0.63
EBITDA Margin 14.52
Particulars MAR 2022 (Values in Cr)
Book Value / Share 137.26
ROE % 7.89
ROCE % 9.65
Total Debt to Total Equity 0.62
EBITDA Margin 21.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 128.42
ROE % 15.22
ROCE % 14.28
Total Debt to Total Equity 0.67
EBITDA Margin 27.19
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 71.69
Total Assets 614.47
Total Liabilities 614.47
Total Equity 358.51
Share Outstanding 2
Price to Book Ratio 2.10
Return on Assets (%) 12.50
Return on Capital (%) 16.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 59.83
Total Assets 547.83
Total Liabilities 547.83
Total Equity 285.16
Share Outstanding 2
Price to Book Ratio 1.39
Return on Assets (%) -4.20
Return on Capital (%) -5.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.32
Total Assets 636.51
Total Liabilities 636.51
Total Equity 312.56
Share Outstanding 2
Price to Book Ratio 0.92
Return on Assets (%) -8.02
Return on Capital (%) -9.65
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 33.60
Total Assets 706.84
Total Liabilities 706.84
Total Equity 371.45
Share Outstanding 2
Price to Book Ratio 1.50
Return on Assets (%) 2.18
Return on Capital (%) 2.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 44.53
Total Assets 687.07
Total Liabilities 687.07
Total Equity 360.29
Share Outstanding 2
Price to Book Ratio 1.95
Return on Assets (%) 6.62
Return on Capital (%) 7.72
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 61.95
Total Assets 622.46
Total Liabilities 622.46
Total Equity 379.95
Share Outstanding 2
Price to Book Ratio 2.10
Return on Assets (%) 10.86
Return on Capital (%) 13.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 56.63
Total Assets 564.57
Total Liabilities 564.57
Total Equity 314.22
Share Outstanding 2
Price to Book Ratio 1.39
Return on Assets (%) -3.31
Return on Capital (%) -4.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.11
Total Assets 663.85
Total Liabilities 663.85
Total Equity 336.05
Share Outstanding 2
Price to Book Ratio 0.92
Return on Assets (%) -8.58
Return on Capital (%) -10.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 30.74
Total Assets 712.64
Total Liabilities 712.64
Total Equity 395.97
Share Outstanding 2
Price to Book Ratio 1.50
Return on Assets (%) 4.24
Return on Capital (%) 4.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 41.30
Total Assets 682.53
Total Liabilities 682.53
Total Equity 370.44
Share Outstanding 2
Price to Book Ratio 1.95
Return on Assets (%) 7.61
Return on Capital (%) 8.66
Particulars MAR 2025 (Values in Cr)
Net Income 83.20
Cash from Operations 43.67
Cash from Investing -0.15
Cash from Financing -50.86
Net change in Cash -10.12
Free Cash Flow 65.80
Particulars MAR 2024 (Values in Cr)
Net Income -9.87
Cash from Operations 104.32
Cash from Investing -15.49
Cash from Financing -90.85
Net change in Cash -1.00
Free Cash Flow 123.53
Particulars MAR 2023 (Values in Cr)
Net Income -51.30
Cash from Operations 112.90
Cash from Investing -55.40
Cash from Financing -41.37
Net change in Cash 19.31
Free Cash Flow 153.38
Particulars MAR 2022 (Values in Cr)
Net Income 26.94
Cash from Operations 52.74
Cash from Investing -26.03
Cash from Financing -21.57
Net change in Cash -4.17
Free Cash Flow 89.87
Particulars MAR 2021 (Values in Cr)
Net Income 51.63
Cash from Operations 76.11
Cash from Investing -41.54
Cash from Financing -1.14
Net change in Cash 19.90
Free Cash Flow 131.38
Particulars MAR 2025 (Values in Cr)
Net Income 74.42
Cash from Operations 36.59
Cash from Investing 0.40
Cash from Financing -50.90
Net change in Cash -16.67
Free Cash Flow 58.73
Particulars MAR 2024 (Values in Cr)
Net Income -4.60
Cash from Operations 104.00
Cash from Investing -15.14
Cash from Financing -90.85
Net change in Cash -0.98
Free Cash Flow 123.21
Particulars MAR 2023 (Values in Cr)
Net Income -57.97
Cash from Operations 119.40
Cash from Investing -63.53
Cash from Financing -41.25
Net change in Cash 18.96
Free Cash Flow 159.89
Particulars MAR 2022 (Values in Cr)
Net Income 42.56
Cash from Operations 59.68
Cash from Investing -32.46
Cash from Financing -21.76
Net change in Cash -3.81
Free Cash Flow 96.81
Particulars MAR 2021 (Values in Cr)
Net Income 63.22
Cash from Operations 76.44
Cash from Investing -43.60
Cash from Financing -1.32
Net change in Cash 18.02
Free Cash Flow 131.36
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
GLAXOSMITHKLINE PHARMA LT 2332.85 41.07 17.42 39519.89 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

Fermenta Biotech Ltd shareholding pattern

Holding
35.88%
64.08%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Fermenta Biotech Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
345.00 2.31 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 327.90
  • 26 Days 318.90
  • 10 Days 326.20
  • 50 Days 310.00
  • 12 Days 325.20
  • 100 Days 310.00
  • 20 Days 321.30
  • 200 Days 310.00
331.97 PIVOT
First Support 324.03 First Resistance 345.13 Second Support 310.87 Second Resistance 353.07 Third Support 302.93 Third Resistance 366.23
RSI 59.94 ADX 44.23 MACD 6.29 Williams % R -36.32 Commodity Channel Index (CCI) 59.90
Date 2026-06-19 Week 47715.00 Same Day 34052.00 Month 31207.00
1 Year -0.01 3 Year -0.02
Over 1 Month
14.63% down
Over 1 Year
0.00% down
Over 3 Months
5.90% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

Fermenta Biotech Ltd Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
06 Aug 2025 2.5 Final 06 Aug 2025 Equity shares
06 Aug 2024 1.25 Final 06 Aug 2024 Equity shares
22 Sep 2023 1.25 Final 22 Sep 2023 Equity shares
04 Aug 2022 1.25 Final 05 Aug 2022 Equity shares
25 Aug 2021 2.5 Final 27 Aug 2021 Equity shares
22 Nov 2019 5.0 Interim 25 Nov 2019 Equity shares
28 Jun 2019 1.25 Final 02 Jul 2019 Equity shares
19 Sep 2018 1.25 Final 22 Sep 2018 Equity shares
21 Sep 2017 2.5 Final 23 Sep 2017 Equity shares
19 Sep 2016 2.5 Final 21 Sep 2016 Equity shares
10 Sep 2014 2.5 Final 12 Sep 2014 Equity shares
24 Feb 2014 7.5 Interim 25 Feb 2014 Equity shares
13 Sep 2012 15.0 Final 15 Sep 2012 Equity shares
05 Jul 2012 15.0 Interim 06 Jul 2012 Equity shares
23 Feb 2012 15.0 Interim 24 Feb 2012 Equity shares
15 Sep 2011 10.0 Final 17 Sep 2011 Equity shares
22 Feb 2011 15.0 Interim 23 Feb 2011 Equity shares
15 Sep 2010 7.5 Final 17 Sep 2010 Equity shares
03 Jun 2010 7.5 Interim 04 Jun 2010 Equity shares
17 Sep 2009 7.5 Final 19 Sep 2009 Equity shares
29 Jun 2009 7.5 Interim 30 Jun 2009 Equity shares
18 Sep 2008 10.0 Final 20 Sep 2008 Equity shares
06 Sep 2007 5.0 Final 08 Sep 2007 Equity shares
08 Sep 2005 0.0 Final 10 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
14 Feb 2020 13 Feb 2020 2:1
09 Aug 2018 08 Aug 2018 1:1
Ex-Date Old FV NEW FV Record Date
08 Aug 2018 10.0 5.0 09 Aug 2018
Dividend date Dividend amount Dividend type Record date Instrument type
06 Aug 2025 2.5 Final 06 Aug 2025 Equity shares
06 Aug 2024 1.25 Final 06 Aug 2024 Equity shares
22 Sep 2023 1.25 Final 22 Sep 2023 Equity shares
04 Aug 2022 1.25 Final 05 Aug 2022 Equity shares
25 Aug 2021 2.5 Final 27 Aug 2021 Equity shares
22 Nov 2019 5.0 Interim 25 Nov 2019 Equity shares
28 Jun 2019 1.25 Final 02 Jul 2019 Equity shares
19 Sep 2018 1.25 Final 22 Sep 2018 Equity shares
21 Sep 2017 2.5 Final 23 Sep 2017 Equity shares
19 Sep 2016 2.5 Final 21 Sep 2016 Equity shares
10 Sep 2014 2.5 Final 12 Sep 2014 Equity shares
24 Feb 2014 7.5 Interim 25 Feb 2014 Equity shares
13 Sep 2012 15.0 Final 15 Sep 2012 Equity shares
05 Jul 2012 15.0 Interim 06 Jul 2012 Equity shares
23 Feb 2012 15.0 Interim 24 Feb 2012 Equity shares
15 Sep 2011 10.0 Final 17 Sep 2011 Equity shares
22 Feb 2011 15.0 Interim 23 Feb 2011 Equity shares
15 Sep 2010 7.5 Final 17 Sep 2010 Equity shares
03 Jun 2010 7.5 Interim 04 Jun 2010 Equity shares
17 Sep 2009 7.5 Final 19 Sep 2009 Equity shares
29 Jun 2009 7.5 Interim 30 Jun 2009 Equity shares
18 Sep 2008 10.0 Final 20 Sep 2008 Equity shares
06 Sep 2007 5.0 Final 08 Sep 2007 Equity shares
08 Sep 2005 0.0 Final 10 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
14 Feb 2020 13 Feb 2020 2:1
09 Aug 2018 08 Aug 2018 1:1
Ex-Date Old FV NEW FV Record Date
08 Aug 2018 10.0 5.0 09 Aug 2018

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fermenta Biotech Ltd?

Answer Field

Fermenta Biotech Ltd share price is for NSE ₹ 342.60 & for BSE ₹ 342.00 as on Jun 22 2026 03:30 PM.

What is the Market Cap of Fermenta Biotech Ltd Share?

Answer Field

The market cap of Fermenta Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 22 2026 03:30 PM.

What is the 52 Week High and Low of Fermenta Biotech Ltd?

Answer Field

The 52 Week High and Low of Fermenta Biotech Ltd for NSE is ₹ 356.85 and ₹ 248.85 and for BSE is ₹ 399.00 and ₹ 256.40.

What is 1 year return for Fermenta Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Fermenta Biotech Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM the price-to-earnings (PE) ratio for Fermenta Biotech Ltd share is 15.49.

What is the PB ratio of Fermenta Biotech Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM, the price-to-book (PB) ratio for Fermenta Biotech Ltd share is 143.79.

How to Buy Fermenta Biotech Ltd Share?

Answer Field

You can trade in Fermenta Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fermenta Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Fermenta Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fermenta Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|